PMID- 29156239 OWN - NLM STAT- MEDLINE DCOM- 20180917 LR - 20190201 IS - 1873-6823 (Electronic) IS - 0741-8329 (Print) IS - 0741-8329 (Linking) VI - 66 DP - 2018 Feb TI - Examining the effects of alcohol on GABA(A) receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells. PG - 45-53 LID - S0741-8329(17)30713-9 [pii] LID - 10.1016/j.alcohol.2017.08.005 [doi] AB - Factors influencing the development of alcohol-use disorder (AUD) are complex and heterogeneous. While animal models have been crucial to identifying actions of alcohol on neural cells, human-derived in vitro systems that reflect an individual's genetic background hold promise in furthering our understanding of the molecular and functional effects of alcohol exposure and the pathophysiology of AUD. In this report, we utilized induced pluripotent stem cell (iPSCs)-derived neural cell cultures obtained from healthy individuals (CTLs) and those with alcohol dependence (ADs) to 1) examine the effect of 21-day alcohol exposure on mRNA expression of three genes encoding GABA(A) receptor subunits (GABRA1, GABRG2, and GABRD) using quantitative PCR, and 2) examine the effect of acute and chronic alcohol exposure on GABA-evoked currents using whole-cell patch-clamp electrophysiology. iPSCs from CTLs and ADs were differentiated into neural cultures enriched for forebrain-type excitatory glutamate neurons. Following 21-day alcohol exposure, significant treatment effects were observed in GABRA1, GABRG2, and GABRD mRNA expression. A modestly significant interaction between treatment and donor phenotype was observed for GABRD, which was increased in cell cultures derived from ADs. No effect of acute or chronic alcohol was observed on GABA-evoked currents in neurons from either CTLs or ADs. This work extends findings examining the effects of alcohol on the GABA(A) receptor in human cell in vitro model systems. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Lieberman, Richard AU - Lieberman R AD - Alcohol Research Center, Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, 06030-1410, USA. FAU - Kranzler, Henry R AU - Kranzler HR AD - Center for Studies of Addiction, Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, 19104, USA; VISN4 MIRECC, Crescenz Philadelphia VAMC, Philadelphia, PA, 19104, USA. FAU - Levine, Eric S AU - Levine ES AD - Department of Neuroscience, University of Connecticut School of Medicine, Farmington, CT, 06030, USA. FAU - Covault, Jonathan AU - Covault J AD - Alcohol Research Center, Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, 06030-1410, USA; Institute for Systems Genomics, University of Connecticut, Storrs, CT, 06268, USA. Electronic address: jocovault@uchc.edu. LA - eng GR - K24 AA013736/AA/NIAAA NIH HHS/United States GR - M01 RR006192/RR/NCRR NIH HHS/United States GR - R01 AA015606/AA/NIAAA NIH HHS/United States GR - R01 AA023192/AA/NIAAA NIH HHS/United States GR - P60 AA003510/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20170812 PL - United States TA - Alcohol JT - Alcohol (Fayetteville, N.Y.) JID - 8502311 RN - 0 (GABRA1 protein, human) RN - 0 (GABRD protein, human) RN - 0 (GABRG2 protein, human) RN - 0 (RNA, Messenger) RN - 0 (Receptors, GABA-A) RN - 3K9958V90M (Ethanol) SB - IM MH - Adult MH - Alcoholism/genetics/*metabolism/pathology MH - Case-Control Studies MH - Cells, Cultured MH - Ethanol/*toxicity MH - Female MH - Humans MH - Male MH - Membrane Potentials MH - Middle Aged MH - Neural Stem Cells/*drug effects/metabolism MH - Pluripotent Stem Cells/*drug effects/metabolism MH - RNA, Messenger/genetics/*metabolism MH - Receptors, GABA-A/*drug effects/genetics/metabolism MH - Up-Regulation PMC - PMC5743620 MID - NIHMS921808 OTO - NOTNLM OT - Alcohol-use disorder OT - Electrophysiology OT - GABA receptor OT - Gene expression OT - Induced pluripotent stem cells OT - iPSC COIS- conflicts of interest Dr. Kranzler has served as a consultant, CME speaker, or advisory board member for the following companies: Indivior, Lundbeck, and Pfizer. He is a member of the Alcohol Clinical Trials Group of the American Society of Clinical Psychopharmacology, which is supported by Abbvie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, and Xenoport. EDAT- 2017/11/21 06:00 MHDA- 2018/09/18 06:00 PMCR- 2019/02/01 CRDT- 2017/11/21 06:00 PHST- 2017/03/21 00:00 [received] PHST- 2017/08/03 00:00 [revised] PHST- 2017/08/05 00:00 [accepted] PHST- 2017/11/21 06:00 [pubmed] PHST- 2018/09/18 06:00 [medline] PHST- 2017/11/21 06:00 [entrez] PHST- 2019/02/01 00:00 [pmc-release] AID - S0741-8329(17)30713-9 [pii] AID - 10.1016/j.alcohol.2017.08.005 [doi] PST - ppublish SO - Alcohol. 2018 Feb;66:45-53. doi: 10.1016/j.alcohol.2017.08.005. Epub 2017 Aug 12.